Papers/PMID:26039623
Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.
Journal of hypertension2015The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
K(+) — decreases diastolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×2“Potassium supplementation resulted in reduction of SBP by 4.7 mmHg [95% confidence interval (CI) 2.4-7.0] and DBP by 3.5 mmHg (95% CI 1.3-5.7) in all patients.”
Quoted verbatim from Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Non-medicated normotensive or hypertensive adults, all patients pooled (15 randomized trials of potassium supplementation)
Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.2015PMID:2603962310.1097/HJH.0000000000000611Permalink
K(+) — decreases systolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×4“Potassium supplementation resulted in reduction of SBP by 4.7 mmHg [95% confidence interval (CI) 2.4-7.0] and DBP by 3.5 mmHg (95% CI 1.3-5.7) in all patients.”
Quoted verbatim from Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Non-medicated normotensive or hypertensive adults, all patients pooled (15 randomized trials of potassium supplementation)
Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.2015PMID:2603962310.1097/HJH.0000000000000611Permalink